Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13863-13878
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13863
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13863
Table 3 Acquired and hereditary thrombotic risk factors in inflammatory bowel disease patients
Factors | Mechanism |
Acquired | |
Inflammation | Hypercoagulation, vascular endothelial injury |
Immobilization | Stasis |
Indwelling IV catheters | Vascular injury |
Dehydration | Stasis |
Steroid use | Hypercoagulation |
Oral contraceptives | Hypercoagulation |
Surgery | Stasis, hypercoagulation, vascular injury |
Pregnancy | Stasis, hypercoagulation |
Cancer | Hypercoagulation |
Infections | Hypercoagulation |
Age | Hypercoagulation |
Smoking | Hypercoagulation |
Hereditary | |
Proteins C and S deficiencies | Hypercoagulation |
Antithrombin deficiency | Hypercoagulation |
Factor V Leiden | Hypercoagulation |
Hyperhomocysteinemia-MTHFR gene mutation | Hypercoagulation |
Prothrombin gene mutation G20210A | Hypercoagulation |
Dysfibrinogenemia | Hypercoagulation |
- Citation: Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism. World J Gastroenterol 2014; 20(38): 13863-13878
- URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13863.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13863